CA2759873A1 - Influenza hemagglutinin compositions and uses thereof - Google Patents
Influenza hemagglutinin compositions and uses thereof Download PDFInfo
- Publication number
- CA2759873A1 CA2759873A1 CA2759873A CA2759873A CA2759873A1 CA 2759873 A1 CA2759873 A1 CA 2759873A1 CA 2759873 A CA2759873 A CA 2759873A CA 2759873 A CA2759873 A CA 2759873A CA 2759873 A1 CA2759873 A1 CA 2759873A1
- Authority
- CA
- Canada
- Prior art keywords
- ectodomain
- influenza
- seq
- amino acid
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159262 | 2009-04-30 | ||
| EP09159262.6 | 2009-04-30 | ||
| PCT/EP2010/055944 WO2010125202A1 (en) | 2009-04-30 | 2010-04-30 | Influenza hemagglutinin compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2759873A1 true CA2759873A1 (en) | 2010-11-04 |
Family
ID=42790940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2759873A Abandoned CA2759873A1 (en) | 2009-04-30 | 2010-04-30 | Influenza hemagglutinin compositions and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120263743A1 (https=) |
| EP (1) | EP2424570A1 (https=) |
| JP (1) | JP2012525134A (https=) |
| CN (1) | CN102573915B (https=) |
| AU (1) | AU2010243490A1 (https=) |
| CA (1) | CA2759873A1 (https=) |
| NZ (1) | NZ596058A (https=) |
| SG (1) | SG175382A1 (https=) |
| WO (1) | WO2010125202A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106822887A (zh) * | 2017-01-26 | 2017-06-13 | 中国科学院微生物研究所 | 一种流感病毒四价亚单位疫苗及其应用 |
| SG11202109850SA (en) | 2019-03-13 | 2021-10-28 | Generation Bio Co | Non-viral dna vectors and uses thereof for expressing fviii therapeutics |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2327382T3 (es) * | 1999-07-20 | 2009-10-29 | Morphosys Ag | Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro. |
| US7264810B2 (en) * | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| DE60234375D1 (de) * | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| ES2316628T3 (es) * | 2001-11-07 | 2009-04-16 | Cytos Biotechnology Ag | Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas. |
| US7138252B2 (en) * | 2002-07-17 | 2006-11-21 | Cytos Biotechnology Ag | Molecular antigen arrays |
| RU2375076C2 (ru) * | 2003-07-10 | 2009-12-10 | Цитос Биотехнологи Аг | Укомплектованные вирусоподобные частицы |
| CN101023103A (zh) * | 2004-09-21 | 2007-08-22 | 赛托斯生物技术公司 | 包含ap205外壳蛋白和抗原性多肽的融合蛋白的病毒样颗粒 |
| MX2007003171A (es) * | 2004-09-21 | 2007-05-23 | Cytos Biotechnology Ag | Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico. |
| US8420102B2 (en) * | 2006-03-07 | 2013-04-16 | Vaxinnate Corporation | Compositions that include hemagglutinin |
| CA2615658A1 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technolgies Inc. | Recombinant flu vaccines |
| AU2006279323B2 (en) * | 2005-08-16 | 2013-08-01 | Merck Sharp & Dohme Corp. | Influenza recombinant subunit vaccine |
| KR101359723B1 (ko) * | 2005-10-18 | 2014-02-05 | 노바백스, 인코포레이티드 | 기능성 인플루엔자 바이러스 유사 입자들 |
| CA2636139A1 (en) * | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| CU23576A1 (es) * | 2006-02-28 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Antígenos vacunales quiméricos contra el virus de la influenza aviar |
| CN101394864A (zh) * | 2006-03-07 | 2009-03-25 | 法克斯因内特公司 | 包含血细胞凝集素的组合物、制造其的方法与使用其的方法 |
-
2010
- 2010-04-30 NZ NZ596058A patent/NZ596058A/xx not_active IP Right Cessation
- 2010-04-30 CA CA2759873A patent/CA2759873A1/en not_active Abandoned
- 2010-04-30 CN CN201080019069.9A patent/CN102573915B/zh not_active Expired - Fee Related
- 2010-04-30 WO PCT/EP2010/055944 patent/WO2010125202A1/en not_active Ceased
- 2010-04-30 AU AU2010243490A patent/AU2010243490A1/en not_active Abandoned
- 2010-04-30 JP JP2012507784A patent/JP2012525134A/ja active Pending
- 2010-04-30 EP EP10719754A patent/EP2424570A1/en not_active Withdrawn
- 2010-04-30 SG SG2011079225A patent/SG175382A1/en unknown
- 2010-04-30 US US13/318,099 patent/US20120263743A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012525134A (ja) | 2012-10-22 |
| SG175382A1 (en) | 2011-12-29 |
| EP2424570A1 (en) | 2012-03-07 |
| NZ596058A (en) | 2013-08-30 |
| CN102573915A (zh) | 2012-07-11 |
| WO2010125202A1 (en) | 2010-11-04 |
| CN102573915B (zh) | 2015-02-18 |
| US20120263743A1 (en) | 2012-10-18 |
| AU2010243490A1 (en) | 2011-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12605454B2 (en) | Modified virus-like particles of CMV | |
| RU2540871C2 (ru) | Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин | |
| AU2006224529B2 (en) | Cat allergen fusion proteins and uses thereof | |
| AU2022291431B2 (en) | Treatment of canine atopic dermatitis | |
| AU2005286475A1 (en) | Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide | |
| EP1603590A2 (en) | Influenza virus vaccine | |
| Park et al. | Chemical and biological conjugation strategies for the development of multivalent protein vaccine nanoparticles | |
| US10898569B2 (en) | Treatment of peanut allergy | |
| WO2016087863A1 (en) | Vaccines based on hepatitis b core antigens | |
| US20120263743A1 (en) | Influenza hemagglutinin compositions and uses thereof | |
| WO2025073874A1 (en) | Vaccine composition comprising m2e nanoparticles and ha1 protein | |
| WO2010122164A1 (en) | VIRUS-LIKE PARTICLES OF BACTERIOPHAGE φCB5 | |
| RU2852174C1 (ru) | Рекомбинантная вакцина против вируса гриппа а человека и способ ее получения | |
| WO2007039458A2 (en) | Hiv peptide conjugates and uses thereof | |
| HK40077650A (zh) | Cmv的修饰病毒样颗粒 | |
| BR112017008266B1 (pt) | Partícula semelhante a vírus (vlp) modificada do vírus do mosaico do pepino (cmv) e composição farmacêutica | |
| BR122024008858A2 (pt) | Uso de uma partícula semelhante a vírus (vlp) modificada do vírus do mosaico do pepino (cmv), ou uma composição compreendendo a referida partícula no tratamento de uma doença, distúrbio ou condição em um animal ou ser humano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20160502 |